Yesterday, Bernard Arnault passed Jeff Bezos to become the world's richest person.
Here’s the story 🧵
Bernard Jean Étienne Arnault[1] (French: [bɛʁnaʁ ʒɑ̃ etjɛn aʁno]; born 5 March 1949) is a French investor, businessman and art collector.[2][3]
He is the chairman and chief executive of LVMH Moët Hennessy – Louis Vuitton SE, the world's largest luxury goods company.[4] A centibillionaire, Arnault is one of the wealthiest men in the world according to a 2021 Forbes report.[5]
Bernard Jean Étienne Arnault was born on 5 March 1949, in Roubaix, France.[6][7] His mother, Marie-Josèphe Savinel, daughter of Étienne Savinel, had a "fascination for Dior". His father, manufacturer Jean Léon Arnault, a graduate of École Centrale Paris,
owned the civil engineering company Ferret-Savinel.[7]
Arnault was educated at the Lycée Maxence Van Der Meersch in Roubaix, and the Lycée Faidherbe in Lille.[8][9] In 1971, he graduated from the École Polytechnique, France's leading engineering school, and began work for…
his father's company.[7] Three years later, after he convinced his father to shift the focus of the company to real estate, Ferret-Savinel sold the industrial construction division and was renamed Ferinel.
Following the acquisition of a textile company and relocation of their headquarters, the company renamed the real estate branch to the George V Group. The real estate assets were later sold to Compagnie Générale des Eaux (CGE), eventually becoming Nexity.
I’m happy to see our “great healthcare for everyone” vision getting closer to reality. This was an uphill battle with a lot of bumps in the road.
We’ve always believed that everyone deserves access to great health, and with the money we already spend, we should be able to do this 3x over. But digital-only approaches are not enough.
We need an omnichannel approach that includes clinics, virtual care and devices. These have existed independently in the market, but no one has integrated them in a way that reduces friction for patients while still keeping it affordable.
We have spent a ridiculous amount of time trying to bring full price transparency to healthcare payments but haven’t been able to make much progress. Let me explain why this is hard 🧵
Our goal is to predict patient responsibility of a visit as soon as possible. Ideally this would be calculated real-time in our EHR so that clinicians can do cost/value trade offs with the patient while ordering things that impact the cost (procedures, diagnostic tests, etc)
The main independent variables here are 1) Complexity of the evaluation (usually 1-5) 2) Additional services like labs, procedures, medical imaging etc which are modeled as CPT codes 3) The nature of the work done (preventive, sick visit, etc) which are mapped to service types
1/ I came to this country 10 years ago on an H1B visa. In this period I started 2 companies: @udemy and @CarbonHealth. Udemy now employs ~700 people, provides ongoing income to 50k instructors and improves employability of tens of millions of Americans by helping close skill gaps
2/ @CarbonHealth employs ~350 ppl and will create 10s of thousands of jobs + health care access in many underserved communities. In addition to working on the frontlines of the pandemic, we have been helping companies reopen safely and thus retain employees.
3/ And this is not just about the immigrant founders. There are million of employees on work visas that are vital to the success of many tech companies. The recent ban on H1, L and J visas will do nothing but hurt companies and cause increased unemployment whitehouse.gov/presidential-a…
1/ Important update: This evening, our lab partner notified us that the FDA updated their FAQ about COVID-19 testing. The update clarifies that at-home sample collection is not covered under the EUA (emergency use authorization) fda.gov/medical-device…
2/ We (@CarbonHealth) are discontinuing the distribution of at-home sample collection kits and contacting the first group of patients to schedule expedited testing in our clinics. FDA supports at-home collection but needs more data to validate its accuracy.
3/ We're doing 50-100 COVID-19 tests in our clinics every day. We will continue to look for additional ways to expand testing capacity. We still believe in the value of at-home sample collection so we will work with our lab partners to accelerate data collection.